Klafki, Hans-Wolfgang
Morgado, Barbara
Wirths, Oliver
Jahn, Olaf
Bauer, Chris
Esselmann, Hermann
Schuchhardt, Johannes
Wiltfang, Jens
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (13GW0479B)
Georg-August-Universität Göttingen
Article History
Received: 29 June 2022
Accepted: 20 October 2022
First Online: 3 December 2022
Declarations
:
: The ethics committee of the University of Goettingen (9/2/16) has approved the collection and archiving of biological samples and clinical data in strictly pseudonymous form in a local biobank and their use in biomarker research. From all participants or their legal representatives written informed consent was obtained prior to the inclusion in the biobank. All procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Not applicable.
: J.W. has been an honorary speaker for Actelion, Amgen, Beeijing Yibai Science and Technology Ltd., Janssen Cilag, Med Update GmbH, Pfizer, Roche Pharma, and has been a member of the advisory boards of Abbott, Biogen, Boehringer Ingelheim, Lilly, MSD Sharp & Dohme, and Roche Pharma and receives fees as a consultant for Immungenetics and Roboscreen. J.W. holds the following patents: PCT/EP 2011 001724 and PCT/EP 2015 052945. J.S. and C.B. are employees of Microdiscovery GmbH, Berlin, Germany. H.-W.K., B.M., O.J., O.W. and H.E. declare no competing interests.